Programme for Intervention in Paediatric Obesity (PinPo)

The PinPo program aims to carry out a comprehensive intervention for children aged 6 to 12 years with childhood obesity (with a BMI greater than the 99th percentile), fostering motivation and encouraging changes toward healthy lifestyle habits to achieve greater adherence and improved health. The program comprises 9 educational sessions designed by specialized professionals from various disciplines (pediatrics, psychology, nursing, nutrition), for a group of 10 children and another group of 10 family members and/or caregivers. These sessions are conducted in a hospital setting every 15 days, each lasting 90 minutes.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Córdoba, Spain
        • Recruiting
        • Hospital Universitario Reina Sofia
        • Contact:
        • Principal Investigator:
          • Mercedes Gil-Campos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children between 6 and 12 years old, with a BMI greater than the 99th percentile according to Cole criteria (2004).

Exclusion Criteria:

  • Children < 6, or > 12 years.
  • Children with chronic diseases or following a therapeutic diet.
  • Children with intervention in other centers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Intervention group for the treatment of childhood obesity
Intervention for children aged 6 to 12 years with childhood obesity (with a BMI greater than the 99th percentile), fostering motivation and encouraging changes toward healthy lifestyle habits to achieve greater adherence and to improve health. The program comprises 9 educational sessions designed by specialized professionals (code of Spanish register: 2007144741729) to be conducted in a health center. The sessions will be held every 15 days, with a duration of 90 minutes for a group of 10 children and another group of 10 family members and/or caregivers. Professionals from different disciplines (paediatricians, psychologists, nurses and nutritionists), will meet with groups of pediatric patients and in another group with their family members or primary caregivers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary intake
Time Frame: 4 months
The daily energy intake will be estimated using data from three internationally validated questionnaires: the adapted Consumption Frequency Questionnaire (CFC), the NHANES Food Questionnaire, and the Kidmed Test. The unit of measurement is kilocalories.
4 months
Diet composition
Time Frame: 4 months
The composition of the diet by macronutrients and micronutrients will be estimated using data from three internationally validated questionnaires: the adapted Consumption Frequency Questionnaire (CFC), the NHANES Food Questionnaire, and the Kidmed Test. The unit of measurement is grams.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity and sedentary behavior
Time Frame: 4 months
Physical activity and sedentary behavior will be assessed in terms of time using an ad hoc questionnaire. The unit of measurement is minutes.
4 months
Screen Time
Time Frame: 4 months
Screen time (including television, computers, cell phones, video games, and consoles) will be assessed in terms of time using an ad hoc questionnaire. The unit of measurement is minutes of screen display.
4 months
Height
Time Frame: 4 months
Height in centimeters is measured with the SECA 213 precision measuring instrument.
4 months
Weight
Time Frame: 4 months
Weight in grams is measured by the precision weighing scale model Tanita 780PMA
4 months
Body mass index
Time Frame: 4 months
Body mass index in kilograms per square meter is calculated.
4 months
Waist circumference
Time Frame: 4 months
Waist circumference in centimeters is measured with a CESCORF measuring tape
4 months
Self-esteem
Time Frame: 4 months
Self-esteem will be evaluated using ad hoc questionnaires. It will be measured by obtaining a score.
4 months
Confidence
Time Frame: 4 months
Confidence will be evaluated using ad hoc questionnaires. It will be measured by obtaining a score.
4 months
Emotional Regulation
Time Frame: 4 months
Emotional regulation will be evaluated using ad hoc questionnaires. It will be measured by obtaining a score.
4 months
Hematological analysis: Hemoglobine
Time Frame: 4 months
Hemoglobin levels are determined in grams per deciliter on an individual basis.
4 months
Hematological analysis: Hematocrite
Time Frame: 4 months
Hematocrite levels are determined in percentage on an individual basis.
4 months
Hematological analysis: Erythrocytes
Time Frame: 4 months
Erythrocytes count is measured in 10e06 units per microliter on an individual basis.
4 months
Hematological analysis: Mean corpuscular volume
Time Frame: 4 months
Mean corpuscular volume is measured in femtoliters on an individual basis.
4 months
Hematological analysis: Mean corpuscular hemoglobin
Time Frame: 4 months
Mean corpuscular hemoglobine is measured in picograms on an individual basis.
4 months
Hematological analysis: Mean corpuscular hemoglobin concentration
Time Frame: 4 months
Mean corpuscular hemoglobine concentration is measured in grams per deciliter on an individual basis.
4 months
Hematological analysis: Red cell blood distribution width
Time Frame: 4 months
Red cell blood distribution width is determined in percentage on an individual basis.
4 months
Hematological analysis: White blood cells
Time Frame: 4 months
White blood cells count is measured in 10e03 units per microliter on an individual basis.
4 months
Hematological analysis: Neutrophils
Time Frame: 4 months
Neutrophils count is measured both in 10e03 units per microliter and in percentage on an individual basis.
4 months
Hematological analysis: Lymphocytes
Time Frame: 4 months
Lymphocytes count is measured both in 10e03 units per microliter and in percentage on an individual basis.
4 months
Hematological analysis: Monocytes
Time Frame: 4 months
Monocytes count is measured both in 10e03 units per microliter and in percentage on an individual basis.
4 months
Hematological analysis: Eosinophils
Time Frame: 4 months
Eosinophils count is measured both in 10e03 units per microliter and in percentage on an individual basis.
4 months
Hematological analysis: Basophiles
Time Frame: 4 months
Basophiles count is measured both in 10e03 units per microliter and in percentage on an individual basis.
4 months
Hematological analysis: Platelets
Time Frame: 4 months
Platelets count is measured in 10e03 units per microliter on an individual basis.
4 months
Hematological analysis: Mean platelet volume
Time Frame: 4 months
Mean platelet volume is measured in femtoliters on an individual basis.
4 months
Biochemical analysis: Glucose
Time Frame: 4 months
Glucose is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Bilirubin
Time Frame: 4 months
Total bilirubin is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma
4 months
Biochemical analysis: Creatinine
Time Frame: 4 months
Creatinine is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Urate
Time Frame: 4 months
Urate is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Urea
Time Frame: 4 months
Urea is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Total protein
Time Frame: 4 months
Total protein is measured both in grams per deciliter and in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Aspartate aminotransferase
Time Frame: 4 months
Aspartate aminotransferase is measured in international units per liter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Alanine aminotransferase
Time Frame: 4 months
Alanine aminotransferase is measured in international units per liter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Gamma-glutamyl transferase
Time Frame: 4 months
Gamma-glutamyl transferase is measured in international units per liter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Alkaline phosphatase
Time Frame: 4 months
Alkaline phosphatase is measured in international units per liter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Total cholesterol
Time Frame: 4 months
Total cholesterol is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: High density lipoproteins
Time Frame: 4 months
High density lipoproteins (HDL) are measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Non-HDL cholesterol
Time Frame: 4 months
Non-HDL cholesterol levels are calculated in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Low density lipoproteins
Time Frame: 4 months
Low density lipoproteins (LDL) are measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Apolipoprotein A1
Time Frame: 4 months
Apolipoprotein A1 is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Apolipoprotein B
Time Frame: 4 months
Apolipoprotein B is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Calcium
Time Frame: 4 months
Calcium is measured both in milligrams per deciliter and in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Potassium
Time Frame: 4 months
Potassium is measured both in millimoles per liter and in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Sodium
Time Frame: 4 months
Sodium is measured in millimoles per liter, in milliequivalents per liter and in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Phosphorus
Time Frame: 4 months
Phosphorus is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Iron
Time Frame: 4 months
Iron is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Magnesium
Time Frame: 4 months
Magnesium is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Zinc
Time Frame: 4 months
Zinc is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Insulin
Time Frame: 4 months
Insulin is measured both in micro international units per liter and in picograms per milliliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Insulin resistance
Time Frame: 4 months
The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index is used to estimate insulin resistance.
4 months
Biochemical analysis: C-reactive protein
Time Frame: 4 months
C-reactive protein is measured in milligrams per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Tumor necrosis factor alpha
Time Frame: 4 months
Tumor necrosis factor alpha is measured in picograms per deciliter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Adiponectin
Time Frame: 4 months
Adiponectin is measured in milligrams per liter on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Energy
Time Frame: 4 months
Adiponectin is measured in milligrams per liter on an individual basis. Analysis performed Energy is determined in kilocalories on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Carbohydrates
Time Frame: 4 months
Adiponectin is measured in milligrams per liter on an individual basis. Analysis performed Carbohydrates are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Sugars
Time Frame: 4 months
Sugars are measured in grams on an individual basis. Analysis performed in plasma.Carbohydrates are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Fiber
Time Frame: 4 months
Fibers are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Polysaccharides
Time Frame: 4 months
Polysaccharides are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Total fat
Time Frame: 4 months
Total fat is measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Saturated fatty acids
Time Frame: 4 months
Saturated fatty acids are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Monounsaturated fatty acids
Time Frame: 4 months
Monounsaturated fatty acids are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Polyunsaturated fatty acids
Time Frame: 4 months
Polyunsaturated fatty acids are measured in grams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin B1
Time Frame: 4 months
Vitamin B1 is measured in milligrams on an individual basis. Analysis performed in plasma
4 months
Biochemical analysis: Vitamin B2
Time Frame: 4 months
Vitamin B2 is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin B3
Time Frame: 4 months
Vitamin B3 is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin B6
Time Frame: 4 months
Vitamin B6 is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin B9
Time Frame: 4 months
Vitamin B9 is measured in micrograms on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin B12
Time Frame: 4 months
Vitamin B12 is measured in micrograms on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin C
Time Frame: 4 months
Vitamin C is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin A
Time Frame: 4 months
Vitamin A is measured in micrograms on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin D
Time Frame: 4 months
Vitamin D is measured in micrograms on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Vitamin E
Time Frame: 4 months
Vitamin E is measured in milligrams on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Carotenes
Time Frame: 4 months
Carotenes are measured in micrograms on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Retinol
Time Frame: 4 months
Retinol is measured in micrograms on an individual basis. Analysis performed in plasma.
4 months
Biochemical analysis: Water
Time Frame: 4 months
Water is measured in grams on an individual basis. Analysis performed in plasma.
4 months
Fecal microbiome: DNA
Time Frame: 4 months
Samples will be homogenized in a Stomacher-400 blender. Subsequently, a QIAamp DNA Stool Mini Kit (QIAGEN, Barcelona, Spain) will be used for the DNA extraction as indicated by the manufacturer with the exception of the incubation at 70 °C, since the samples will be mixed with the lysis buffer and incubated at a temperature of 95 °C to ensure that both Gram-positive and Gram-negative bacteria are lysed. The quantification of the DNA will be conducted with a NanoDrop ND1000 spectrophotometer (Thermo Fisher Scientific, DE, USA) and the DNA yield will be calculated by measuring absorbance ratios spectrophotometrically, including A260/230 nm for salt and phenol contamination and A260/280 nm for protein contamination. The unit of measurement is percentage of abundance.
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Estimated)

March 1, 2032

Study Completion (Estimated)

March 1, 2032

Study Registration Dates

First Submitted

May 27, 2024

First Submitted That Met QC Criteria

June 7, 2024

First Posted (Actual)

June 13, 2024

Study Record Updates

Last Update Posted (Actual)

June 13, 2024

Last Update Submitted That Met QC Criteria

June 7, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PinPo

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Childhood

Clinical Trials on Intervention group for the treatment of childhood obesity

Subscribe